FDA approves treatments from BMS, Genentech and Servier
The U.S. Food and Drug Administration (FDA) gave new or expanded approvals for three treatments targeting serious conditions in the past week: a drug […]
FDA approves treatments from BMS, Genentech and Servier Read More »